Ocular absorption following topical delivery
暂无分享,去创建一个
Tomi Järvinen | Arto Urtti | A. Urtti | K. Järvinen | T. Järvinen | Kristiina Järvinen | T. Järvinen
[1] R. Schoenwald. Ocular pharmacokinetics/pharmacodynamics , 1993 .
[2] M. Maniaci,et al. Expression of keratins K12, K4 and K14 during development of ocular surface epithelium. , 1994, Current eye research.
[3] H F Edelhauser,et al. Comparison of conjunctival and corneal surface areas in rabbit and human. , 1988, Current eye research.
[4] G. Holland,et al. Transscleral iontophoresis of foscarnet. , 1993, American journal of ophthalmology.
[5] O. Geyer,et al. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma. , 1994, American journal of ophthalmology.
[6] V. Lee,et al. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition. , 1992, Experimental eye research.
[7] A. Urtti,et al. Sulfobutyl ether β-cyclodextrin (SBE-β-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits , 1995 .
[8] M. B. Shields,et al. Comparison of two treatment schedules for combined timolol and dipivefrin therapy. , 1986, American journal of ophthalmology.
[9] A. Ludwig,et al. Evaluation of viscous ophthalmic vehicles containing carbomer by slit-lamp fluorophotometry in humans , 1990 .
[10] J. Robinson,et al. The effect of polyethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers , 1992 .
[11] T. F. Patton,et al. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. , 1987, Journal of pharmaceutical sciences.
[12] V. Stella,et al. The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. , 1994, Current eye research.
[13] T. Maren,et al. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. , 1993, Investigative ophthalmology & visual science.
[14] V. Lee,et al. Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit. , 1990, Journal of ocular pharmacology.
[15] A. Konstas,et al. Collagens in the aged human macular sclera. , 1993, Current eye research.
[16] J. Baum,et al. Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit. , 1986, Ophthalmology.
[17] S. I. Saleh,et al. Comparative dissolution characteristics of bropirimine-β-cyclodextrin inclusion complex and its solid dispersion with PEG 6000 , 1993 .
[18] K. Green,et al. Effects of calcium channel blockers on rabbit corneal endothelial function. , 1994, Current eye research.
[19] Niesman Mr. The use of liposomes as drug carriers in ophthalmology. , 1992 .
[20] J. Szejtli,et al. Medicinal Applications of Cyclodextrins , 1994, Medicinal research reviews.
[21] D. Lee,et al. Experimental transscleral iontophoresis of ciprofloxacin. , 1991, Journal of ocular pharmacology.
[22] S. Klyce,et al. Transport processes across the rabbit corneal epithelium: a review. , 1985, Current eye research.
[23] V. H. Lee,et al. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. , 1991, Current eye research.
[24] A. Urtti,et al. Minimizing systemic absorption of topically administered ophthalmic drugs. , 1993, Survey of ophthalmology.
[25] D. Epstein,et al. Additive effect of epinephrine to timolol therapy in primary open angle glaucoma. , 1982, Archives of ophthalmology.
[26] G. Grass,et al. Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement. , 1988, Journal of pharmaceutical sciences.
[27] L. Szente,et al. Proceedings of the Eighth International Symposium on Cyclodextrins , 1982 .
[28] T. Ushiki,et al. The three-dimensional organization of collagen fibrils in the human cornea and sclera. , 1991, Investigative ophthalmology & visual science.
[29] J. Robinson,et al. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. , 1977, Journal of pharmaceutical sciences.
[30] V. H. Lee,et al. Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.
[31] B. Gumbiner,et al. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Schoenwald. Ocular drug delivery. Pharmacokinetic considerations. , 1990, Clinical pharmacokinetics.
[33] J. Hardy,et al. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man , 1986, The Journal of pharmacy and pharmacology.
[34] T. Maren,et al. Ocular pharmacology of sulfonamides: the cornea as barrier and depot. , 1985, Current eye research.
[35] N. Bodor,et al. Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex. , 1993, Journal of pharmaceutical sciences.
[36] J. Robinson,et al. (D) Routes of delivery: Case studies: (7) Ocular delivery of peptide and protein drugs , 1992 .
[37] A. Rozier,et al. Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol , 1992 .
[38] Frank W. Newell,et al. Ophthalmology, principles and concepts , 1969 .
[39] D. Whikehart,et al. Beta-blocking agents inhibit Na+K+ATPase in cultured corneal endothelial and epithelial cells. , 1991, Journal of ocular pharmacology.
[40] S. Choudhury,et al. Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-β-cyclodextrin , 1992 .
[41] M. Kass,et al. Timolol and epinephrine: long-term evaluation of concurrent administration. , 1982, Archives of ophthalmology.
[42] H. Sasaki,et al. Ocular drug interactions involving topically applied timolol in the pigmented rabbit. , 1991, Current eye research.
[43] J. Hanrahan,et al. Anion channels in the apical membrane of mammalian corneal epithelium primary cultures. , 1991, Investigative ophthalmology & visual science.
[44] Robert Gurny,et al. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine , 1993 .
[45] N. McNamara,et al. Stromal acidosis modulates corneal swelling. , 1994, Investigative ophthalmology & visual science.
[46] J. Robinson,et al. Study of the mechanism of interaction of poly(ϵ-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy , 1994 .
[47] C K Hitzenberger,et al. Interferometric measurement of corneal thickness with micrometer precision. , 1994, American journal of ophthalmology.
[48] J. Chang,et al. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations. , 1991, Investigative ophthalmology & visual science.
[49] A. Tønjum. Permeability of horseradish peroxidase in the rabbit corneal epithelium. , 2009, Acta ophthalmologica.
[50] J. Kelly,et al. Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. , 1989, The British journal of ophthalmology.
[51] Joseph R. Robinson,et al. Confocal laser scanning microscopic examination of transport pathways and barriers of some peptides across the cornea , 1990 .
[52] R. Brown,et al. The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine. , 1993, American journal of ophthalmology.
[53] N. Bodor,et al. Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride , 1992 .
[54] V. H. Lee. Mechanisms and facilitation of corneal drug penetration , 1990 .
[55] A. Urtti,et al. Sodium acetate improves the ocular/systemic absorption ratio of timolol applied ocularly in monoisopropyl PVM-MA matrices , 1991 .
[56] J. Rae,et al. Ion channels in ocular epithelia. , 1993, Investigative ophthalmology & visual science.
[57] A. Urtti,et al. Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits , 1990 .
[58] M. F. Sugrue,et al. The pharmacology of antiglaucoma drugs. , 1989, Pharmacology & therapeutics.
[59] M. Tso,et al. Intravitreal delivery of ganciclovir in rabbits by transscleral iontophoresis. , 1994, Journal of ocular pharmacology.
[60] H. Sasaki,et al. Intestinal permeability of ophthalmic beta-blockers for predicting ocular permeability. , 1994, Journal of pharmaceutical sciences.
[61] A. Urtti,et al. Disposition of ophthalmic timolol in treated and untreated rabbit eyes. A multiple and single dose study. , 1984, Experimental eye research.
[62] J. Wolosin,et al. Ontogeny of corneal epithelial tight junctions: stratal locale of biosynthetic activities. , 1993, Investigative ophthalmology & visual science.
[63] J. Robinson,et al. Lacrimal and instilled fluid dynamics in rabbit eyes. , 1973, Journal of pharmaceutical sciences.
[64] K. Green,et al. Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea. , 1992, Current eye research.
[65] J. Szejtli,et al. Cyclodextrins in Pharmacy , 1993 .
[66] Clive G. Wilson,et al. Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .
[67] P. Granström,et al. Timolol-pilocarpine combined vs timolol and pilocarpine given separately. , 1989, American journal of ophthalmology.
[68] Y. Rojanasakul,et al. Transport mechanisms of the cornea: characterization of barrier permselectivity , 1989 .
[69] E. Keates. Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. , 1979, American journal of ophthalmology.
[70] D. Tang-Liu,et al. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. , 1990, Current eye research.
[71] S. S. Davis,et al. Altered ocular absorption and disposition of sodium cromoglycate upon ion‐pair and complex coacervate formation with dodecylbenzyldimethylammonium chloride , 1981, The Journal of pharmacy and pharmacology.
[72] J. Siliciano,et al. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia , 1986, The Journal of cell biology.
[73] P. Agre,et al. Cultured bovine corneal endothelial cells express CHIP28 water channels. , 1993, The American journal of physiology.
[74] M. Doughty,et al. Topographical differences in cell area at the surface of the corneal epithelium of the pigmented rabbit. , 1992, Current eye research.
[75] A. C. Eissens,et al. The effects of cyclodextrins on drug absorption II. In vivo observations , 1990 .
[76] A. Urtti,et al. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits. , 1990, Journal of pharmaceutical sciences.
[77] R. Buck,et al. Influence of ion pairing salts on the transcorneal permeability of ionized sulfonamides. , 1992, Journal of ocular pharmacology.
[78] T. Zimmerman,et al. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion. , 1992, American journal of ophthalmology.
[79] A. Urtti,et al. Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol. , 1989, Journal of ocular pharmacology.
[80] F. B. Hoefle,et al. Recent studies on the nature and function of the corneal endothelial barrier. , 1973, Experimental eye research.
[81] M. Borgers,et al. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium. , 1990, Lens and eye toxicity research.
[82] J. Szejtli. Cyclodextrins in Pharmaceuticals , 1988 .
[83] R. Schoenwald,et al. Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. , 1978, Journal of pharmaceutical sciences.
[84] J. Moyano,et al. Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin , 1995 .
[85] R. Schoenwald,et al. Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors , 1983 .
[86] P. Ellis,et al. Effect of nasolacrimal occlusion on timolol concentrations in the aqueous humor of the human eye. , 1992, Journal of pharmaceutical sciences.
[87] T. F. Patton,et al. Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption , 1987 .
[88] K. Cooper,et al. Single potassium channels in corneal epithelium. , 1990, Investigative ophthalmology & visual science.
[89] J. Robinson,et al. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. , 1979, Journal of pharmaceutical sciences.
[90] S. Tseng,et al. Paracellular permeability of corneal and conjunctival epithelia. , 1989, Investigative ophthalmology & visual science.
[91] T. Nishida,et al. The network structure of corneal fibroblasts in the rat as revealed by scanning electron microscopy. , 1988, Investigative ophthalmology & visual science.
[92] E. Stefánsson,et al. 2-hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations , 1994 .
[93] A. Rozier,et al. Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol , 1989 .
[94] S. Tseng,et al. Conjunctival epithelial cells do not transdifferentiate in organotypic cultures: expression of K12 keratin is restricted to corneal epithelium. , 1994, Current eye research.
[95] John W. Shell. Ophthalmic drug delivery systems , 1984 .
[96] V. Lee,et al. Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit. , 1993, Journal of ocular pharmacology.
[97] T. Sun,et al. In vitro growth and differentiation of rabbit bulbar, fornix, and palpebral conjunctival epithelia. Implications on conjunctival epithelial transdifferentiation and stem cells. , 1993, Investigative ophthalmology & visual science.
[98] R. Borchardt. Assessment of transport barriers using cell and tissue culture systems , 1990 .
[99] B. Saville,et al. Theoretical corneal permeation model for ionizable drugs. , 1993, Journal of ocular pharmacology.
[100] R. Silverman,et al. Epithelial and corneal thickness measurements by high-frequency ultrasound digital signal processing. , 1994, Ophthalmology.
[101] A. Urtti,et al. Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor , 1990 .
[102] J. C. Keister,et al. Limits on optimizing ocular drug delivery. , 1991, Journal of pharmaceutical sciences.
[103] D. Shi,et al. Is It Worthwhile to Add Dipivefrin HCl 0.1 % to Topical β1-, β2-blocker Theraphy?+ , 1989 .
[104] R. Stratford,et al. Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. , 1986, Journal of ocular pharmacology.
[105] T. Nadai,et al. Effect of the interaction of drug-beta-cyclodextrin complex with bile salts on the drug absorption from rat small intestinal lumen. , 1989, Chemical & pharmaceutical bulletin.
[106] Robert Gurny,et al. Design and evaluation of controlled release systems for the eye , 1987 .
[107] U. Kompella,et al. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit. , 1993, Experimental eye research.
[108] D. Maurice. Electrical potential and ion transport across the conjunctiva. , 1973, Experimental eye research.
[109] T. Loftsson,et al. The effect of cyclodextrins on the solubility and stability of medroxyprogesterone acetate and megestrol acetate in aqueous solution , 1993 .
[110] Y. Rojanasakul,et al. The cytoskeleton of the cornea and its role in tight junction permeability , 1991 .
[111] B. S. Winkler,et al. Relationship between fluid transport and in situ inhibition of Na(+)-K+ adenosine triphosphatase in corneal endothelium. , 1994, Investigative ophthalmology & visual science.
[112] T. Nakai,et al. Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in‐vitro , 1987, The Journal of pharmacy and pharmacology.
[113] C. M. Lederer,et al. Drop size of commercial glaucoma medications. , 1986, American journal of ophthalmology.
[114] A. Ludwig,et al. The evaluation of viscous ophthalmic vehicles by slit lamp fluorophotometry in humans , 1989 .
[115] V. H. Lee,et al. Aminopeptidase activity in homogenates of various absorptive mucosae m the albino rabbit: implications in peptide delivery , 1986 .
[116] R. W. Wood,et al. Effects of calcium chelating agents on corneal permeability. , 1985, Investigative ophthalmology & visual science.
[117] Thorsteinn Loftsson,et al. The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations , 1994 .
[118] M. D. McCartney,et al. Rabbit corneal epithelial wound repair: tight junction reformation. , 1992, Current eye research.
[119] T. F. Patton,et al. Age-related differences in ophthalmic drug disposition III. Corneal permeability of pilocarpine in rabbits , 1983 .
[120] J. Szejtli. Cyclodextrins: Properties and Applications , 1990 .
[121] A. Martínez-Palomo,et al. Structure of tight junctions in epithelia with different permeability. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[122] U. Kompella,et al. Active chloride transport in the pigmented rabbit conjunctiva. , 1993, Current eye research.
[123] R. Stone,et al. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate. , 1981, American journal of ophthalmology.
[124] A. Urtti. Delivery of antiglaucoma drugs: ocular vs systemic absorption. , 1994, Journal of ocular pharmacology.
[125] A. Urtti,et al. Systemic absorption of ocular pilocarpine is modified by polymer matrices , 1985 .
[126] M. Itoh,et al. Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.
[127] Benjamin Geiger,et al. Cingulin, a new peripheral component of tight junctions , 1988, Nature.
[128] H. Edelhauser,et al. The developing corneal endothelium: correlation of morphology, hydration and Na/K ATPase pump site density. , 1991, Current eye research.
[129] C. Crosson,et al. Beta-cyclodextrins enhance bioavailability of pilocarpine. , 1993, Current eye research.
[130] R. Huupponen,et al. Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects. , 1986, Journal of ocular pharmacology.
[131] K. Uekama,et al. Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble β-cyclodextrin-epichlorohydrin polymer , 1985 .
[132] A. Urtti,et al. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine. , 1990, Investigative ophthalmology & visual science.
[133] B. Müller,et al. In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product voltaren ophtha. , 1994, Journal of pharmaceutical sciences.
[134] Jos H. Beijnen,et al. Cyclodextrins in the Pharmaceutical Field , 1991 .
[135] Y. Rojanasakul,et al. The effect of drug charge type and charge density on corneal transport , 1992 .
[136] T. F. Patton,et al. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. , 1985, Investigative ophthalmology & visual science.
[137] C. Chiang,et al. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor. , 1990, Journal of ocular pharmacology.
[138] G. Visor. Drug design strategies for ocular therapeutics , 1994 .
[139] B. Gumbiner,et al. Structure, biochemistry, and assembly of epithelial tight junctions. , 1987, The American journal of physiology.
[140] V. H. Lee,et al. Prodrugs for improved ocular drug delivery , 1989 .
[141] Nicholas Bodor,et al. Novel ‘soft’ β-blockers as potential safe antiglaucoma agents , 1988 .
[142] I. Oh,et al. Effect of 2-hydroxypropyl-β-cyclodextrin on the stability of prostaglandin E2 in solution , 1994 .